198 related articles for article (PubMed ID: 24935722)
21. Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients.
Maecker B; von Bergwelt-Baildon MS; Anderson KS; Vonderheide RH; Anderson KC; Nadler LM; Schultze JL
Clin Exp Immunol; 2005 Sep; 141(3):558-62. PubMed ID: 16045747
[TBL] [Abstract][Full Text] [Related]
22. HER-2/neu-derived peptide epitopes are also recognized by cytotoxic CD3(+)CD56(+) (natural killer T) lymphocytes.
Baxevanis CN; Gritzapis AD; Tsitsilonis OE; Katsoulas HL; Papamichail M
Int J Cancer; 2002 Apr; 98(6):864-72. PubMed ID: 11948464
[TBL] [Abstract][Full Text] [Related]
23. Recognition of human renal cell carcinoma and melanoma by HLA-A2-restricted cytotoxic T lymphocytes is mediated by shared peptide epitopes and up-regulated by interferon-gamma.
Bernhard H; Maeurer MJ; Jäger E; Wölfel T; Schneider J; Karbach J; Seliger B; Huber C; Storkus WS; Lotze MT; Meyer zum Büschenfelde KH; Knuth A
Scand J Immunol; 1996 Sep; 44(3):285-92. PubMed ID: 8795723
[TBL] [Abstract][Full Text] [Related]
24. Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy.
Wen YJ; Min R; Tricot G; Barlogie B; Yi Q
Blood; 2002 May; 99(9):3280-5. PubMed ID: 11964294
[TBL] [Abstract][Full Text] [Related]
25. An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions.
Anichini A; Molla A; Mortarini R; Tragni G; Bersani I; Di Nicola M; Gianni AM; Pilotti S; Dunbar R; Cerundolo V; Parmiani G
J Exp Med; 1999 Sep; 190(5):651-67. PubMed ID: 10477550
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of HLA-A*02-restricted Hantaan virus multiple-antigenic peptide for CD8
Ma Y; Tang K; Zhang Y; Zhang C; Zhang Y; Jin B; Ma Y
Virol J; 2020 Jan; 17(1):15. PubMed ID: 32005266
[TBL] [Abstract][Full Text] [Related]
27. Identification of human leucocyte antigen (HLA)-A*0201-restricted cytotoxic T lymphocyte epitopes derived from HLA-DOβ as a novel target for multiple myeloma.
Kang YJ; Zeng W; Song W; Reinhold B; Choi J; Brusic V; Yamashita T; Munshi A; Li C; Minvielle S; Anderson KC; Munshi N; Reinherz EL; Sasada T
Br J Haematol; 2013 Nov; 163(3):343-51. PubMed ID: 24032635
[TBL] [Abstract][Full Text] [Related]
28. Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides.
Tsuchida T; Parker KC; Turner RV; McFarland HF; Coligan JE; Biddison WE
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10859-63. PubMed ID: 7526383
[TBL] [Abstract][Full Text] [Related]
29. Assessment of Safety and Immunogenicity of PVX-410 Vaccine With or Without Lenalidomide in Patients With Smoldering Multiple Myeloma: A Nonrandomized Clinical Trial.
Nooka AK; Wang ML; Yee AJ; Kaufman JL; Bae J; Peterkin D; Richardson PG; Raje NS
JAMA Oncol; 2018 Dec; 4(12):e183267. PubMed ID: 30128502
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic Activity and Memory T Cell Subset Distribution of
Kuznetsova M; Lopatnikova J; Shevchenko J; Silkov A; Maksyutov A; Sennikov S
Front Immunol; 2019; 10():1017. PubMed ID: 31143180
[TBL] [Abstract][Full Text] [Related]
31. Role of 4-1BB (CD137) in the functional activation of cord blood CD28(-)CD8(+) T cells.
Kim YJ; Brutkiewicz RR; Broxmeyer HE
Blood; 2002 Nov; 100(9):3253-60. PubMed ID: 12384425
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel HLA-A(*)0201-restricted CTL epitopes from Pokemon.
Yuan B; Zhao L; Xian R; Zhao G
Cell Immunol; 2012; 274(1-2):54-60. PubMed ID: 22405859
[TBL] [Abstract][Full Text] [Related]
33. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
Shi L; Liu S; Fan GX; Sheng L; Ren HX; Yuan YK
Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665
[TBL] [Abstract][Full Text] [Related]
34. Human memory CTL response specific for influenza A virus is broad and multispecific.
Gianfrani C; Oseroff C; Sidney J; Chesnut RW; Sette A
Hum Immunol; 2000 May; 61(5):438-52. PubMed ID: 10773346
[TBL] [Abstract][Full Text] [Related]
35. Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: identification of virus-specific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein.
Van Epps HL; Schmaljohn CS; Ennis FA
J Virol; 1999 Jul; 73(7):5301-8. PubMed ID: 10364276
[TBL] [Abstract][Full Text] [Related]
36. Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells.
Wen YJ; Barlogie B; Yi Q
Blood; 2001 Mar; 97(6):1750-5. PubMed ID: 11238117
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-12 increases proliferation and interferon-gamma production but not cytolytic activity of human antigen-specific effector memory cytotoxic T lymphocytes: power of the effect depends on the functional avidity of the T cell and the antigen concentration.
Bontkes HJ; Ruizendaal JJ; Kramer D; Meijer CJ; Schreurs MW; Hooijberg E
Hum Immunol; 2005 Nov; 66(11):1137-45. PubMed ID: 16571414
[TBL] [Abstract][Full Text] [Related]
38. A modified HLA-A*0201-restricted CTL epitope from human oncoprotein (hPEBP4) induces more efficient antitumor responses.
Sun W; Shi J; Wu J; Zhang J; Chen H; Li Y; Liu S; Wu Y; Tian Z; Cao X; Li N
Cell Mol Immunol; 2018 Aug; 15(8):768-781. PubMed ID: 29375131
[TBL] [Abstract][Full Text] [Related]
39. Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes.
Corbet S; Nielsen HV; Vinner L; Lauemoller S; Therrien D; Tang S; Kronborg G; Mathiesen L; Chaplin P; Brunak S; Buus S; Fomsgaard A
J Gen Virol; 2003 Sep; 84(Pt 9):2409-2421. PubMed ID: 12917462
[TBL] [Abstract][Full Text] [Related]
40. Presentation of peptides by cultured monocytes or activated T cells allows specific priming of human cytotoxic T lymphocytes in vitro.
Gagliardi MC; De Petrillo G; Salemi S; Boffa L; Longobardi MG; Dellabona P; Casorati G; Tanigaki N; Harris R; Lanzavecchia A
Int Immunol; 1995 Nov; 7(11):1741-52. PubMed ID: 8580072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
